MTIX Micro Therapeutics (MM)

Micro Therapeutics to Report 2004 Third Quarter Financial Results and Host Conference Call on November 4 IRVINE, Calif., Nov. 1 /PRNewswire-FirstCall/ -- Micro Therapeutics, Inc. (MTI) (NASDAQ:MTIX) announced today it will release its 2004 third quarter financial results on November 4, 2004. The company also said that Tom Wilder, MTI's president and chief executive officer, Harold Hurwitz, chief financial officer, and James Corbett, chairman, will host a conference call that same day at 8:00 a.m. PST (11:00 a.m. EST) to review the company's financial results and operations. The conference call will be available to interested parties through a live audio webcast at http://www.1mti.com/. The call will be archived and accessible on the same Web site for approximately one year. About Micro Therapeutics, Inc. Micro Therapeutics develops, manufactures and markets minimally invasive medical devices for the diagnosis and treatment of vascular disorders. The Company's primary focus is on catheter based technologies and products for the interventional neuroradiology market. Micro Therapeutics' products include the Sapphire(R) and NXT lines of embolic coils, the ONYX(R) liquid embolic system, and a broad line of micro catheters, guidewires, and occlusion balloons that are utilized in the treatment of cerebral vascular disorders. DATASOURCE: Micro Therapeutics, Inc. CONTACT: Harold Hurwitz of Micro Therapeutics, Inc., +1-949-837-3700; or Rob Whetstone or Robert Jaffe, both of PondelWilkinson Inc., +1-310-279-5980, for Micro Therapeutics, Inc. Web site: http://www.1mti.com/

Copyright